Covered recipient · General Payments record
LAURA R KIDD
Allopathic & Osteopathic Physicians Pathology Anatomic Pathology & Clinical Pathology
General Payments · PY2018
$129.85
- Reported across 7 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2018 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $129.85 | 7 |
By paying entity
PY2018 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Focal Therapeutics, Inc. | $43.78 | 1 |
| INSYS Therapeutics Inc | $24.45 | 2 |
| Celgene Corporation | $20.48 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $17.43 | 1 |
| E.R. Squibb & Sons, L.L.C. | $13.17 | 1 |
| Merck Sharp & Dohme Corporation | $10.54 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2018 | $129.85 | 7 |
Payment records · PY2018 (7)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Celgene Corporation | $20.48 | 11/29/2018 | Food and Beverage | Undisputed | 01/23/2026 | 595498555 | CMS |
| E.R. Squibb & Sons, L.L.C. | $13.17 | 12/14/2018 | Food and Beverage | Undisputed | 01/23/2026 | 571890767 | CMS |
| Focal Therapeutics, Inc. | $43.78 | 02/07/2018 | Food and Beverage | Undisputed | 01/23/2026 | 615602583 | CMS |
| INSYS Therapeutics Inc | $11.99 | 01/22/2018 | Food and Beverage | Undisputed | 01/23/2026 | 603953723 | CMS |
| INSYS Therapeutics Inc | $12.46 | 05/03/2018 | Food and Beverage | Undisputed | 01/23/2026 | 603957815 | CMS |
| Merck Sharp & Dohme Corporation | $10.54 | 05/02/2018 | Food and Beverage | Undisputed | 01/23/2026 | 604353979 | CMS |
| Puma Biotechnology, Inc. | $17.43 | 03/28/2018 | Food and Beverage | Undisputed | 01/23/2026 | 612868133 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018
- Source files
- Dataset page · Bulk file · PY2018
- Generated from
- OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.